词条 | Mary Reilly (academic) |
释义 |
| name = Mary Reilly | alma_mater = University College Dublin | workplaces = National Hospital for Neurology and Neurosurgery | known_for = Inherited neuropathies }} Mary M. Reilly FRCP is an Irish neurologist who works at National Hospital for Neurology and Neurosurgery. She studies peripheral neuropathy. She is the President of the Association of British Neurologists. Early life and educationReilly studied medicine at University College Dublin, graduating in 1986.[1][2] She worked for a few years as a neurologist at St. Vincent's University Hospital, before joining Anita Harding at the National Hospital for Neurology and Neurosurgery in 1991.[1][3][4][5] Reilly has spoken of how much she admired her supervisor, and attributes her clinical interests to Harding.[6] Reilly earned her medical doctorate in 1996, focussing on familial amyloid polyneuropathy.[1][7][8] She completed her neurological training at Royal Free Hospital and Guy's Hospital, [1] training with P. K. Thomas and Richard Hughes.[9] CareerAt the National Hospital for Neurology and Neurosurgery Reilly specialises in inherited neuropathies.[10][11] She was made consultant neurologist in 1998[3] and a Fellow of the Royal College of Physicians in 2002.[4] She began to study neuromuscular disease, [12] in particular Charcot–Marie–Tooth disease.[13][14] In 2004, she found that Vitamin C could be used to improve symptoms in mouse models of CMT1A (Charcot–Marie–Tooth disease type 1A).[15] She established a randomized controlled trial with colleagues in Italy to evaluate the efficacy of Vitamin C on CMT1A.[15] The UK part of the trial consisted of 50 participants, and found that whilst Vitamin C is safe, it does not slow the progression of the disease.[15] Although the trial was not a success, it developed new neuropathy outcome measures.[15] Her research includes the identification of genes such as BICD2 and methionyl-tRNA synthetase (MARS);[10][16][17] she has already conducted functional analysis of IGHMBP2.[18] Reilly works with Muscular Dystrophy UK on muscle-wasting conditions.[19] She has also worked on new biomarkers for disease progression.[20] CMT parents suffer from damaged motor nerves, which results in muscles weakening, and ultimately allows fat to accumulate in muscles; MRI outcome measures could monitor intramuscular fat accumulation, and detect muscle water changes that preceded fat accumulation.[20].[21] Reilly identified that calf muscle fat friction maps are an outcome measure in patients with CMT1A, with calf muscle fat increased significantly in patients with CMT1A[22] She received a $1,000,000 grant from the Muscular Dystrophy Association to evaluate MRI protocols for monitoring changes in muscles from CMT.[23][21] In 2010 Reilly was appointed Professor of Clinical Neurology at University College London.[24] She leads the Division of Clinical Neurology and Medical Research Council Centre for Neuromuscular Diseases.[25][26] With the MRC Centre for Neuromuscular Diseases and Muscular Dystrophy UK, Reilly runs an annual translational neuromuscular diseases meeting, which includes a patient day to discuss inherited neuropathies.[26] Along with CMT, Reilly has worked on hereditary sensory and autonomic neuropathies and carpal tunnel syndrome in inherited neuropathies.[27] Reilly contributed to the 2013 Handbook of Clinical Neurology, [28] and wrote a chapter for the 2016 Springer Publishing collection Neuromuscular Disease: Case Studies from Queen Square.[29][30] Reilly has served as President of the British Peripheral Nerve Society and the International Peripheral Nerve Society.[31] In 2015 she was appointed President-elect of the Association of British Neurologists.[3] She became the first woman to take the role in 2017.[3] References1. ^1 2 3 {{Cite web|url=http://www.treat-nmd.eu/contacts/mary.reilly/|title=TREAT-NMD : Mary Reilly|website=www.treat-nmd.eu|access-date=2019-01-23}} {{DEFAULTSORT:Reilly, Mary}}2. ^{{Cite web|url=http://www.ucd.ie/medicine/news/2017/may2017/|title=May 2017|website=UCD School of Medicine & Medical Science|access-date=2019-01-23}} 3. ^1 2 3 {{Cite web|url=https://www.ucl.ac.uk/ion/news/2015/mar/professor-mary-reilly-elected-be-first-female-president-association-british|title=Professor Mary Reilly is elected to be the first female President of the Association of British Neurologists in 83 years|last=UCL|date=2015-03-24|website=UCL Queen Square Institute of Neurology|access-date=2019-01-23}} 4. ^1 {{Cite web|url=http://www.ucd.ie/medicine/news/2017/may2017/|title=May 2017|website=UCD School of Medicine & Medical Science|access-date=2019-01-23}} 5. ^{{Cite journal|last=Reilly|first=Mary M.|last2=King|first2=Rosalind H. M.|date=1993|title=Familial Amyloid Polyneuropathy|journal=Brain Pathology|volume=3|issue=2|pages=165–176|doi=10.1111/j.1750-3639.1993.tb00741.x|issn=1750-3639}} 6. ^{{Cite web|url=https://medium.com/understanding-as-a-service-uaas/remembering-my-first-boss-the-great-clinical-neurologist-anita-harding-on-international-womens-3412f968ee6e|title=Remembering my first boss, the great Clinical Neurologist Anita Harding, on International Women's…|last=Cummins|first=Stephen|date=2018-03-08|website=Medium|access-date=2019-01-23}} 7. ^{{Cite web|url=http://rcp-medicine-conference.com/wp-content/uploads/2017/09/Mary-Reilly-final-.pdf|title=Professor Mary M. Reilly Biography|last=|first=|date=|website=RCP|archive-url=|archive-date=|dead-url=|access-date=2019-01-23}} 8. ^{{Cite journal|last=Reilly|first=M.M.|last2=Adams|first2=D.|last3=Booth|first3=D.R.|last4=Davis|first4=M.B.|last5=Said|first5=G.|last6=Laubriat-Bianchin|first6=M.|last7=Pepys|first7=M.B.|last8=Thomas|first8=P.K.|last9=Harding|first9=A.E.|date=1996|title=Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy|journal=Neuromuscular Disorders|volume=6|pages=S24|doi=10.1016/0960-8966(96)88834-1|issn=0960-8966}} 9. ^{{Cite web|url=https://www.react-congress.org/2012/speaker/prof-mary-m-reilly-uk/index.html|title=Prof. Mary M Reilly, UK {{!}} RE-ACT Congress|website=www.react-congress.org|access-date=2019-01-23}} 10. ^1 {{Cite web|url=http://iris.ucl.ac.uk/iris/browse/profile?upi=MREIL38|title=Iris View Profile|website=iris.ucl.ac.uk|access-date=2019-01-23}} 11. ^{{Cite journal|last=Reilly|first=Mary M.|date=2009-04-01|title=Classification and diagnosis of the inherited neuropathies|journal=Annals of Indian Academy of Neurology|volume=12|issue=2|pages=80–8|doi=10.4103/0972-2327.53075|issn=0972-2327|pmid=20142852|pmc=2812746}} 12. ^{{Cite journal|last=Hanna|first=Michael G.|last2=Reilly|first2=Mary M.|date=2002-12-01|title=Genetic neuromuscular disease|url=https://jnnp.bmj.com/content/73/suppl_2/ii12|journal=Journal of Neurology, Neurosurgery & Psychiatry|volume=73|issue=suppl 2|pages=ii12–ii21|doi=10.1136/jnnp.73.suppl_2.ii12|issn=0022-3050|pmid=12536154|pmc=1765608}} 13. ^{{Cite journal|last=Reilly|first=Mary M.|last2=Evans|first2=Matthew R. B.|last3=Rossor|first3=Alexander M.|date=2015-06-01|title=A practical approach to the genetic neuropathies|url=https://pn.bmj.com/content/15/3/187|journal=Practical Neurology|volume=15|issue=3|pages=187–198|doi=10.1136/practneurol-2015-001095|issn=1474-7758|pmid=25898997}} 14. ^{{Cite journal|last=Reilly|first=Mary M.|last2=Murphy|first2=Sinéad M.|last3=Laurá|first3=Matilde|date=2011|title=Charcot-Marie-Tooth disease|journal=Journal of the Peripheral Nervous System|volume=16|issue=1|pages=1–14|doi=10.1111/j.1529-8027.2011.00324.x|pmid=21504497|issn=1529-8027}} 15. ^1 2 3 {{Cite web|url=https://www.musculardystrophyuk.org/grants/first-clinical-trial-for-charcot-marie-tooth-disease/|title=First clinical trial for Charcot Marie Tooth Disease|website=www.musculardystrophyuk.org|access-date=2019-01-23}} 16. ^{{Cite journal|last=Consortium (INC)|first=Inherited Neuropathy|last2=Züchner|first2=Stephan|last3=Reilly|first3=Mary M.|last4=Antonellis|first4=Anthony|last5=Yang|first5=Xiang-Lei|last6=Speziani|first6=Fiorella|last7=Hadjivassilious|first7=Marios|last8=Yo-Tsen|first8=Liu|last9=Guo|first9=Min|date=2013-11-01|title=Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2|url=https://jnnp.bmj.com/content/84/11/1247|journal=J Neurol Neurosurg Psychiatry|volume=84|issue=11|pages=1247–1249|doi=10.1136/jnnp-2013-305049|issn=0022-3050|pmc=3796032|pmid=23729695}} 17. ^{{Cite journal|last=Oates|first=Emily C.|last2=Rossor|first2=Alexander M.|last3=Hafezparast|first3=Majid|last4=Gonzalez|first4=Michael|last5=Speziani|first5=Fiorella|last6=MacArthur|first6=Daniel G.|last7=Lek|first7=Monkol|last8=Cottenie|first8=Ellen|last9=Scoto|first9=Mariacristina|date=2013-06-06|title=Mutations in BICD2 Cause Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraplegia|journal=American Journal of Human Genetics|volume=92|issue=6|pages=965–973|doi=10.1016/j.ajhg.2013.04.018|issn=0002-9297|pmc=3675232|pmid=23664120}} 18. ^{{Cite journal|last=Cottenie|first=Ellen|last2=Kochanski|first2=Andrzej|last3=Jordanova|first3=Albena|last4=Bansagi|first4=Boglarka|last5=Zimon|first5=Magdalena|last6=Horga|first6=Alejandro|last7=Jaunmuktane|first7=Zane|last8=Saveri|first8=Paola|last9=Rasic|first9=Vedrana Milic|date=2014-11-06|title=Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2|journal=American Journal of Human Genetics|volume=95|issue=5|pages=590–601|doi=10.1016/j.ajhg.2014.10.002|issn=0002-9297|pmc=4225647|pmid=25439726}} 19. ^{{Cite web|url=https://www.musculardystrophyuk.org/progress-in-research/working-in-partnership/|title=Working in partnership - Muscular Dystrophy UK|website=www.musculardystrophyuk.org|access-date=2019-01-23}} 20. ^1 {{Cite journal|last=Morrow|first=Jasper M|last2=Sinclair|first2=Christopher D J|last3=Fischmann|first3=Arne|last4=Machado|first4=Pedro M|last5=Reilly|first5=Mary M|last6=Yousry|first6=Tarek A|last7=Thornton|first7=John S|last8=Hanna|first8=Michael G|date=January 2016|title=MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study|journal=The Lancet. Neurology|volume=15|issue=1|pages=65–77|doi=10.1016/S1474-4422(15)00242-2|issn=1474-4422|pmc=4672173|pmid=26549782}} 21. ^1 {{Cite web|url=https://strongly.mda.org/critical-biomarker-development-cmt-receives-1-million-mda/|title=Critical Biomarker Development for CMT Receives $1 Million Boost from MDA|last=Staff|first=M. D. A.|date=2018-07-09|website=MDA|access-date=2019-01-23}} 22. ^{{Cite journal|last=Reilly|first=Mary M.|last2=Shy|first2=Michael E.|last3=Thornton|first3=John S.|last4=Nopoulos|first4=Peggy|last5=Hanna|first5=Michael G.|last6=Yousry|first6=Tarek A.|last7=Shah|first7=Sachit|last8=Thedens|first8=Daniel|last9=Sinclair|first9=Christopher D. J.|date=2018-09-18|title=Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A|journal=Neurology|volume=91|issue=12|pages=e1125–e1129|doi=10.1212/WNL.0000000000006214|issn=0028-3878|pmid=30120135|pmc=6161551}} 23. ^{{Cite web|url=https://www.mda.org/press-releases/mda-funds-development-critical-biomarker-charcot-marie-tooth-disease|title=MDA Funds Development of a Critical Biomarker for Charcot Marie Tooth Disease|date=2018-07-09|website=Muscular Dystrophy Association|access-date=2019-01-23}} 24. ^{{Cite web|url=https://neuropathycommons.org/mary-reilly-md-frcp-frcpi|title=Mary Reilly, MD, FRCP, FRCPI {{!}} Neuropathy Commons|website=neuropathycommons.org|access-date=2019-01-23}} 25. ^{{Cite web|url=http://www.uclh.nhs.uk/ourservices/servicea-z/neuro/cnd/Pages/Home.aspx|title=Neuromuscular disease|website=www.uclh.nhs.uk|access-date=2019-01-23}} 26. ^1 {{Citation|last=Muscular Dystrophy UK|title=Professor Mary Reilly talks about the development of treatments for Charcot-Marie-Tooth disease.|url=https://www.youtube.com/watch?v=bQI9HQNOf-o|access-date=2019-01-23}} 27. ^{{Cite web|url=https://www.emedevents.com/speaker-profile/mary-m-reilly-32437|title=Mary M. Reilly - Head, Professor, Consultant of Neurology in London, England, United Kingdom {{!}} eMedEvents|website=www.emedevents.com|access-date=2019-01-23}} 28. ^{{Citation|last=Murphy|first=Sinéad M.|title=Chapter 12 - DNA testing in hereditary neuropathies|date=2013-01-01|chapter-url=http://www.sciencedirect.com/science/article/pii/B9780444529022000126|journal=Handbook of Clinical Neurology|volume=115|pages=213–232|editor-last=Said|editor-first=Gérard|series=Peripheral Nerve Disorders|publisher=Elsevier|access-date=2019-01-23|last2=Laurá|first2=Matilde|last3=Reilly|first3=Mary M.|editor2-last=Krarup|editor2-first=Christian|doi=10.1016/B978-0-444-52902-2.00012-6|pmid=23931782|chapter=DNA testing in hereditary neuropathies|isbn=9780444529022}} 29. ^{{Cite book|date=2017|editor-last=Manji|editor-first=Hadi|editor2-last=Turner|editor2-first=Chris|editor3-last=Evans|editor3-first=Matthew R. B.|title=Neuromuscular Disease|doi=10.1007/978-1-4471-2389-7|isbn=978-1-4471-2388-0}} 30. ^{{Citation|last=Mahdi-Rogers|first=Mohamed|title=A Woman Who Could Not Wear High Heels|date=2017|work=Neuromuscular Disease : Case Studies from Queen Square|pages=3–6|editor-last=Manji|editor-first=Hadi|publisher=Springer London|doi=10.1007/978-1-4471-2389-7_1|isbn=9781447123897|last2=Laurá|first2=Matilde|last3=Reilly|first3=Mary M.|editor2-last=Turner|editor2-first=Chris|editor3-last=Evans|editor3-first=Matthew R. B.}} 31. ^{{Cite web|url=https://www.eanpages.org/2017/07/07/interview-with-mary-reilly-president-of-the-peripheral-nerve-society-pns/|title=Interview with Mary Reilly - President of the Peripheral Nerve society (PNS)|last=Editor|website=eanpages - News Blog of the European Academy of Neurology|access-date=2019-01-23}} 6 : Women neurologists|Irish women medical doctors|Irish neurologists|Alumni of University College Dublin|Living people|Year of birth missing (living people) |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。